Asia Pacific

Experience in Asia Pacific

PPD provides clients with the knowledge and experience they need to navigate the region’s regulatory environment and understand the culture. Our regional and country experts reduce local challenges, such as running into problems with obtaining approvals for studies that include placebos, and expedite clients’ project startups.

Our offices are located in Australia, China, Hong Kong, India, Japan, Korea, Malaysia, New Zealand, the Philippines, Singapore, Taiwan, Thailand and Vietnam, and we provide additional clinical trial coverage in Indonesia.

Region’s Advantages

• Patient availability: With a population of more than 4 billion, Asia Pacific offers a large and diverse treatment-naive patient pool.
• High retention rate: The strong doctor-patient relationships in the region facilitate high retention rates.
• Lower costs: Investigator and site costs are lower across the region, resulting in substantial savings compared to the United States or Europe.

CRO Services

PPD has more than 1,400 professionals in Asia Pacific. PPD provides a broad range of research and development services in the region, from discovery through Phase IV for biopharmaceutical clients. We offer such services as drug discovery, clinical trial management and monitoring, biostatistics, data management, drug management, global central lab, medical affairs, patient recruitment, quality assurance, regulatory affairs and site selection.